Search
Oculis Holding AG
OCSAdd to Watchlist
14.120USD
+0.590+4.36%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
876.03MMarket Cap
LossP/E TTM
More Details of Oculis Holding AG Company
Oculis Holding AG is a Switzerland-based company primally engaged in biotechnology sector. The Company is focused on the development of eye disease treatment for ophthalmology. It includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.
Oculis Holding AG Info
Ticker SymbolOCS
Company nameOculis Holding AG
IPO dateMar 03, 2023
CEOSherif (Riad)
Number of employees49
Security typeOrdinary Share
Fiscal year-endMar 03
AddressBahnhofstrasse 20
CityZUG
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountrySwitzerland
Postal code6300
Phone41417113960
Websitehttps://oculis.com/
Ticker SymbolOCS
IPO dateMar 03, 2023
CEOSherif (Riad)
Company Executives of Oculis Holding AG
Name
Name/Position
Position
Shareholding
Change
Mr. Martijn Kleijwegt
Mr. Martijn Kleijwegt
Independent Director
Independent Director
470.97K
--
Mr. Pall Ragnar Johannesson
Mr. Pall Ragnar Johannesson
Chief Business Officer
Chief Business Officer
288.43K
+6.80%
Mr. Lionel Carnot
Mr. Lionel Carnot
Independent Director
Independent Director
90.75K
--
Ms. Sylvia Cheung, CPA
Ms. Sylvia Cheung, CPA
Chief Financial Officer
Chief Financial Officer
77.32K
+6.80%
Ms. Geraldine O'Keeffe
Ms. Geraldine O'Keeffe
Independent Director
Independent Director
20.59K
--
Ms. Christina M. Ackermann
Ms. Christina M. Ackermann
Independent Director
Independent Director
6.53K
--
Dr. Riad Sherif, M.D.
Dr. Riad Sherif, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Anthony A. (Tony) Rosenberg
Mr. Anthony A. (Tony) Rosenberg
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Arshad M. Khanani, M.D.
Mr. Arshad M. Khanani, M.D.
Independent Director
Independent Director
--
--
Mr. Robert K. Warner
Mr. Robert K. Warner
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Martijn Kleijwegt
Mr. Martijn Kleijwegt
Independent Director
Independent Director
470.97K
--
Mr. Pall Ragnar Johannesson
Mr. Pall Ragnar Johannesson
Chief Business Officer
Chief Business Officer
288.43K
+6.80%
Mr. Lionel Carnot
Mr. Lionel Carnot
Independent Director
Independent Director
90.75K
--
Ms. Sylvia Cheung, CPA
Ms. Sylvia Cheung, CPA
Chief Financial Officer
Chief Financial Officer
77.32K
+6.80%
Ms. Geraldine O'Keeffe
Ms. Geraldine O'Keeffe
Independent Director
Independent Director
20.59K
--
Ms. Christina M. Ackermann
Ms. Christina M. Ackermann
Independent Director
Independent Director
6.53K
--
FAQs
Who are the top five shareholders of Oculis Holding AG?
The top five shareholders of Oculis Holding AG are: Mr. Martijn Kleijwegt
How many institutions hold shares of Oculis Holding AG (OCS)?
As of 2026Q1, 72 institutions hold shares of Oculis Holding AG, with a combined market value of approximately 27.88M, accounting for 54.68% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 2538023.00.